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Abstract
Background Immediate implant reconstruction after a conser-
vative mastectomy is an attractive option made easier by
prosthetic devices. Titanized polypropylene meshes are used
as a hammock to cover the lower lateral implant pole. We
conducted a prospective nonrandomized single-institution
study of reconstructions using titanium-coated meshes either
in a standard muscular mesh pocket or in a complete subcu-
taneous approach. The complete subcutaneous approach
means to wrap an implant with titanized mesh in order to
position the implant subcutaneously and spare muscles.
Methods Between November 2011 and January 2014, we
performed immediate implant breast reconstructions after con-
servative mastectomies using TiLoop® Bra, either with the
standard retropectoral or with a prepectoral approach. Selec-
tion criteria included only women with normal Body Mass
Index (BMI), no large and very ptotic breasts, no history of
smoking, no diabetes, and no previous radiotherapy. We
analyzed short-term outcomes of such procedures and com-
pared the outcomes to evaluate implant losses and surgical
complications.
Results A total of 73 mastectomies were performed. Group 1
comprised 29 women, 5 bilateral procedures, 34 reconstruc-
tions, using the standard muscular mesh pocket. Group 2
comprised 34 women, 5 bilateral procedures, 39 reconstruc-
tions with the prepectoral subcutaneous technique. Baseline
and oncologic characteristics were homogeneous between the
two groups. After a median follow-up period of 13 and
12 months, respectively, no implant losses were recorded in
group 1, and one implant loss was recorded in group 2. We
registered three surgical complications in group 1 and two
surgical complications in group 2.
Conclusions Titanium-coated polypropylene meshes, as a
tool for immediate definitive implant breast reconstruction,
resulted as safe and effective in a short-term analysis, both for
a retropectoral and a totally subcutaneous implant placement.
Long-term results are forthcoming. A strict selection is man-
datory to achieve optimal results.
Level of Evidence: Level II, therapeutic study.
Keywords Titanium-coatedmesh . Immediate breast
reconstruction . Conservative mastectomy . Implant-based
breast reconstruction . Subcutaneous implant positioning
Introduction
Skin-sparing and nipple-sparing mastectomies (SSM, NSM),
which are defined conservative mastectomies [1], have
changed perspectives and possibil i t ies of breast
reconstruction.
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Implant-based breast reconstruction (IBBR) is the most
frequently used technique worldwide. This is true both in
USA [2] and in Europe. The adoption of a delayed procedure
using a tissue expander (TE) before the definitive implant is
the easiest and the most common solution. Nonetheless, an
immediate IBBR with a definitive implant is sometimes ac-
complished. A full muscular pocket is not always feasible,
particularly for large implants. The use of prosthetic devices
allows surgeons to perform a mastectomy with immediate
definitive implant placement and as a one-step procedure with
greater frequency than in the past.
Many solutions have been developed in the past years,
spanning from biological acellular dermal matrix (ADM) to
meshes of diverse prosthetic materials. Every device is usually
adopted as a sling. The technical employment is based on the
principle of implant lower lateral pole coverage in a
hammock-like fashion after major pectoralis muscle detach-
ment. ADMs have been used for many years as compared to
prosthetic meshes and are approved both in Europe and in
USA; a large amount of data are present in literature on their
use and results [3–12]. ADMs should be considered, to date,
the gold standard for soft tissue replacement in immediate
IBBR. Notwithstanding their utility and importance, ADMs
have shown, not always at a statistically significant level, a
trend toward a higher complication rate when compared to
standard whole muscular pocket implant reconstruction, par-
ticularly infections and seromas [13–18].
Titanium-coated polypropylene mesh (TCPM), TiLoop®
Bra (TiLOOP® Bra, pfm medical, Cologne, Germany), has
been approved for use in breast surgery since 2008 in Europe.
It is a very useful prosthetic mesh, proven to be safe and
effective in IBBR [19]. In the largest series present in literature
to date regarding TiLoop® in IBBR [20], with more than 200
cases, the major complication rate is 13.4 %, minor compli-
cation rate is 15.6 %, and implant loss rate is 8.7 %.
After having used ADM and TiLoop®meshes alternatively
for some years, we designed and started a single-institution
nonrandomized prospective study on TiLoop® Bra. The aim
of the present study was to compare the TiLoop® Bra use in
IBBR either in its standard sling fashion for a retropectoral
implant positioning or in an implant full coverage for a
prepectoral totally subcutaneous position. This type of ap-
proach comprises the only use of mesh without any muscle
dissection and submuscular pocket.
Patients and methods
Study design
In 2011, we designed a prospective, nonrandomized clinical
study of immediate IBBR bymeans of a titanium-coated mesh
used in two different ways. Patients scheduled at our
institution for conservative mastectomies, either NSM or
SSM, followed by immediate definitive prosthetic reconstruc-
tion using TCPM, specifically the TiLoop® Bra, would have
been entered into a computer-based database and followed up
every 2 months after surgery. The two types of reconstruction,
e.g., the mesh use and implant positioning, adopted in our
Breast Unit were not randomized and were left at the single
surgeon preference after a thorough conversation with each
patient. Cases with the traditional retropectoral muscular mesh
implant coveragemade up the first group, group 1, while those
with a mesh-only coverage, prepectoral and totally subcuta-
neous, comprised the second one, group 2. Patients were
included in the study only if the following selection criteria
were met: age less than 80 years, normal BMI (range 18.5–
24.9), small-medium size breasts, and ptosis grade of the first
and second degree according to the three-tier Regnault ptosis
scale [21]. Exclusion criteria were previous breast surgery, T4
and metastatic cancers, refusal to sign the consent, comorbid-
ities (diabetes, renal failure, congestive heart failure, cardio-
vascular diseases including hypertension, pulmonary diseases,
chronic hepatic diseases, and metabolic diseases), smoking,
and previous radiotherapy on the chest wall. A detailed in-
formed consent including a technical surgery description and
complication information had to be signed by every woman.
The prospective digital database of the study cases includes all
baseline characteristics, oncologic data, surgical technical in-
formation, and short-term outcomes. The database also in-
cludes postoperative complications and follow-up outpatient
visits. Short-term outcomes were classified as follows: IBBR
failure (e.g., implant removal) and surgical complications,
namely, skin-nipple necrosis, seroma, wound dehiscence,
wound or skin flap infection, hematoma, and atopic versus
graft reaction. The study was conducted in accordance with
the Declaration of Helsinki, and after, the Hospital Ethical
Committee reviewed and approved the study protocol and all
its related documentation.
A 2-year enrollment period was initially considered in the
study protocol for the first analysis of results with a prediction
of approximately 30 cases per group. Two independent phy-
sicians were in charge of the study control with periodic
evaluation of interim results. The study would have been
stopped in a case of statistically significant adverse events.
Case data (patients’ baseline characteristics, tumor staging,
biomolecular details, and short-term outcomes of the two
groups) were intended to be compared considering the total
count of mastectomy procedures rather than the number of
women operated on.
Surgical technique
Group 1 After mastectomy completion, once skin flaps were
judged adequate, pectoralis major muscle dissection and de-
tachment from chest wall were performed. Serratus muscle
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was spared and not used. A retropectoral pocket was hence
created. An adequately selected implant was put in place, and
a TCPM (TiLoop® Bra, Large Extralight Sheet) was then
employed as a hammock to cover the lower lateral pole of
the implant. Two Jackson-Pratt (JP) drains were left in place,
one under the combined pocket and the other in a more
superficial subcutaneous site, and removed only if less than
40 cc/24 h were collected after two consecutive days. An
additional drain was employed dependent on axilla manage-
ment. An antibiotic treatment was started intravenously
30 min before incision and then given per os for 4 postoper-
ative days. A physical rehabilitation therapist followed the
patient from postoperative day 1 as needed for exercise and
movement suggestions.
Group 2 An identical approach was carried out for the second
group of patients except for the TCPM and muscular manage-
ment. Once skin-fat flaps were considered adequate, a
TiLoop® Bra mesh bag was adjusted around the implant but
without cutting the mesh itself, in order to prevent sharp edges
or spikes. Using reabsorbable sutures, a TiLoop®sheet
(TiLoop® Bra, Large Extralight Sheet) was folded onto itself
to create a bag which eventually functioned as a pocket for a
breast implant (Fig. 1). In the case of larger implants, two
TCPM sheets were used and stitched together. The TCPM
bag, with the implant inside, was then placed in a prepectoral
totally subcutaneous position. Medial and lateral borders were
usually secured to the muscular fascia with few interrupted
reabsorbable sutures. Only one JP drain was left, and no
physical therapist consult was normally required.
Statistical analysis
Analysis of recorded data was done using the IBM SPSS
Statistics software (SPSS version 19, SPSS Inc., Chicago,
IL, USA). Significance of differences was calculated using
nonparametric tests. Mann-Whitney U test was used for con-
tinuous variables, while the chi-square test or Fisher’s exact
test was used where appropriate. A two-tailed p value inferior
to 0.05 was considered statistically significant.
Results
Between November 2011 and January 2014, a total of 73
mastectomies were enrolled in the study. Ten were bilateral
procedures, meaning that 63 women were submitted to this
type of surgery. Thirty-four immediate IBBR performed on 29
women, five bilateral, were accomplished with a retropectoral
implant in group 1 (G1). A total count of 39 immediate
reconstructions with a TiLoop® Bra mesh total implant cov-
erage and without any muscular dissection were performed on
34 women, five bilateral mastectomies in group 2 (G2). Sur-
gery was performed for oncologic reasons, either for malig-
nant diseases or as prophylaxis in all cases. No statistically
significant difference was present in terms of patients’ age and
BMI. Oncologic variables were similar as well as the propor-
tion of SSM and NSM in G1 and in G2. Neoadjuvant therapy
was performed only in one patient in G1 and in four cases in
G2. Median follow-up and range were 13 (3–29) months for
G1 patients and 12 (3–27) months for G2. Differences were
not significant. Overall complications rate was comparable.
Among the first group of patients, we had no failures (removal
of implant) while one case was registered in G2. We recorded
three cases of complications in G1: two skin flap infections
and one wound dehiscence. Two surgical complications, be-
sides the one implant loss, were reported in G2: one nipple
partial necrosis and one case of hematoma. All baseline,
oncologic, and short-term outcome data are listed in Table 1
for both groups.
Failure rate and complication rate were not statistically
different among the two groups.
Discussion
Silicone implants are widely used worldwide, being IBBR by
far the preferred way of breast reconstructive surgery after
mastectomy. Prosthesis coverage by a whole muscular pocket
in order to prevent skin flap/wound dehiscence and implant
exposure has been the safest choice for years until recently.
With the introduction of soft tissue replacement devices, either
biological or synthetic, a combined muscular prosthetic
Fig. 1 Complete implant wrapping with TiLoop® Bra for subcutaneous
placement
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Table 1 Comparison of patients’
characteristics, oncologic data,
and complications between the
two groups
Muscular mesh pocket G1 Mash bag pocket G2 p value
N cases (%) 34 (47) 39 (53)
Age median (range) 51 (27–69) 47 (31–76) 0.12
BMI median (range) 23 (19–25) 23 (19–24) 0.11
Intervention N cases (%)
SSM 5 (15) 3 (8)
NSM 29 (85) 36 (92)
0.46
Pathology N cases (%)
pT0 4 (12) 11 (28)
pTis 7 (20) 7 (18)
pT1mic 3 (9) 0 (0)
pT1a 0 (0) 4 (10)
pT1b 5 (15) 3 (8)
pT1c 11 (32) 11 (28)
pT2 3 (9) 3 (8)
pT3 1 (3) 0 (0)
0.12
pN 0 25 (73) 26 (66)
pN 1mi 2 (6) 1 (3)
pN 1a 4 (12) 7 (18)
pN 2a 2 (6) 4 (10)
pN 3a 1 (3) 1 (3)
0.82
Vascular invasion (+) 5 (15) 5 (13) 0.54
ER+ 25 (73) 25 (64) 0.27
PgR+ 23 (68) 21 (54) 0.16
Ki67>16 % 19 (56) 16 (41) 0.15
Staging
0 11 (32) 17 (43)
IA 14 (41) 10 (25)
IB 1 (3) 1 (3)
IIA 5 (15) 5 (13)
IIB 1 (3) 1 (3)
IIIA 1 (3) 4 (10)
IIIB 0 (0) 0 (0)
IIIC 1 (3) 1 (3)
0.75
Neoadjuvant therapy: N cases (%) 1 (3) 4 (10) 0.36
Mortality N cases (%) 0 (0) 0 (0) 1.00
Overall complications N cases (%) 3 (9) 3 (8) 0.59
Implant loss 0 (0) 1 (3) 0.54
Skin-nipple necrosis 0 (0) 1 (3) 0.54
Seroma 0(0) 0(0) 1.00
Wound dehiscence 1 (3) 0 (0) 0.47
Wound-skin infection 2 (6) 0 (0) 0.22
Hematoma 0(0) 1(3) 0.54
Atopic reaction versus prosthesis 0 (0) 0 (0) 1.00
Reoperation 0 (0) 1 (3) 0.54
Months of FU median (range) 13 (3–29) 12 (3–27) 0.43
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pocket has become an attractive option. Such devices give the
opportunity of enlarging the pocket and thus performing a
definitive IBBR with a good volume silicone prosthesis in a
one-step fashion. We started our experience with ADM and
TiLoop® Bra meshes many years ago and eventually decided
to start a prospective study with two different possibilities of
TiLoop® adoption in November 2011. Titanized mesh can be
used either as a sling to cover the lower lateral implant pole,
which is cranially placed in a standard retropectoral position
or as a whole implant wrapping device for a prepectoral totally
subcutaneous implant position. There are few publications
about breast implant subcutaneous positioning [22–24] and
no publications with TCPM. The rationale for our prepectoral
TiLoop®Bra use was simply based on the premise that TCPM
shows significant minor flogistic histopathological reactions
when compared to other polypropylene meshes [25–27].
TCPM proved to be safe when placed under the mastectomy
cutaneous flap in the lower lateral definitive prosthesis pole
[19, 20], and in addition, meshes are traditionally placed
where mechanical stress forces are highest. Moreover,
TiLoop®Bra use could have a role in the reduction of capsular
contracture as well [28]. Therefore, we assumed that a mesh
coverage could be extended to all the implant surface without
muscle detachment and in a prepectoral position. In our anal-
ysis of results, cases were considered as the overall number of
procedures and not simply the number of patients, thus
entailing that a bilateral intervention was like two cases, both
in terms of characteristics and complications. Results of our
prospective series are encouraging with comparable failure
and complication rate and in line with the current literature
on this topic. We recorded just one implant loss due to a large
flap necrosis in G2 (prepectoral implants). This case required
implant and mesh removal 7 days after mastectomy. ATEwas
hence placed in a full muscular pocket under pectoralis major
and serratus, which were not previously dissected and there-
fore still viable and safe. A latissimus dorsi flap was used to
replace the skin flap necrosis area. Complication rate was
similar and very limited. Except for the cases of implant
removal and hematoma in G2, which required a second
intervention, all the other complications were treated
conservatively with antibiotics and minor surgical de-
bridement, healing always within a month period. Flap
bruise and ecchymosis not requiring invasive procedures
or reintervention were not considered hematomas. We
did not register any seroma, meaning a long-lasting
serous fluid drainage or collection needing aspiration
from the mastectomy site. Seromas and infections are
drawbacks of ADM use, highlighted in published stud-
ies on this topic [13–16], both ranging from 0 to 9 %,
in direct to implant reconstruction as reported by a quite
recent literature review [16]. We have been using ADM
for years, and we completed our learning curve in soft
tissue replacement devices using ADM.
Our limited number of surgical complications might be
explained by the quite restrictive selection criteria of the study
design and by our previous experience with ADM.
We must acknowledge that our results in this first analysis
are limited to short-term outcomes and, therefore, surgical
complications. Obviously, we did not include any of those
complications that need a second-step plastic revision surgery,
such as capsular contracture, palpable implant signs, visible
implant’s profile or poor cosmetic results, which require a
longer period of observation and will be part of a future
evaluation.
Our rates are lower than those reported in the largest series
on TiLoop® use in breast reconstruction [20]. Lower rates
could be explained by the different selection criteria. Specif-
ically, the selection criteria in the aforementioned multicentric
study was more diverse in patient characteristics including
reconstructions after modified radical mastectomy and de-
layed IBBR with TE use.
The criteria in our study limited the technique to
circumscribed cases. From our experience, we can possibly
assume that a subcutaneous implant within a mesh bag is
considerably safe in normal weight, nonsmoking, nondiabetic,
small-medium breast-sized women. On the other hand, there
could be adverse risk to thin subjects with large and ptotic
breasts and patients with previous breast surgery, irradi-
ation or risk factors such as obesity, history of smoking,
diabetes, and other comorbidities. A hypothetical advan-
tage in terms of pain and functional recovery is implied
in the mesh bag technique although it was not part of
the evaluation of the present study.
In our series, a postoperative radiation therapy was adopted
only in cases of more than three positive lymph nodes, and it
was limited to axillary and clavicular stations, according to
our regional and institutional multi-disciplinary guidelines.
Thus, no thoracic wall postoperative radiation therapy was
adopted in any of our cases.
Other limits of our study are the following: A scientific and
reproducible functional test was not performed, and the surgi-
cal site infection rate cannot be considered completely reliable
in every case since a minimum follow-up of 1 year was not
completed for all patients, in accordance to Centers for Dis-
ease Control (CDC) 2010 guidelines for breast implant sur-
gery [29]. Further follow-up, analyses of long-term cosmetic
results, and evaluation of pain, functional recovery, and pos-
sibly costs would definitely confirm usefulness of this ap-
proach and use of TCPM.
In conclusion, we can state that a titanium-coated
polypropylene mesh used as a tool for immediate defin-
itive IBBR resulted, in the short term, to be safe and
effective both for a retropectoral and totally subcutane-
ous implant placement. Long-term results are forthcom-
ing. Strict adherence to selection criteria is mandatory to
achieve optimal results.
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